Navigation Links
Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy

daily nebivolol effectively lowers blood pressure to a similar extent in both obese and non-obese hypertensive patients.

"These study results are promising and add to the growing body of data that support nebivolol as a useful treatment for hypertension across a broad population of patients," says Neil Shusterman, MD, Senior Vice President, Clinical Development, Forest Research Institute. "We feel that nebivolol will offer patients and physicians a unique option for managing high blood pressure."

About Nebivolol

Nebivolol is a selective beta 1-adrenergic (cardioselective) receptor antagonist with vasodilating properties and is already approved and successfully marketed for the treatment of hypertension in more than 50 countries outside of North America.

About Forest Laboratories and Its Products

Forest Laboratories is a US-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R) (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.

    * Benicar is a registered trademark of Daiichi Sankyo, Inc., and C
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
(Date:5/6/2015)... , May 6, 2015 ... What does the future hold for the ... brand new report shows you potential revenues to 2025, ... Our new 189 page report provides 115 tables, charts, ... most lucrative areas in the industry and the future ...
(Date:5/6/2015)... , May 6, 2015  TriStar Wellness ... company that targets opportunities in the advanced wound ... Portland, Oregon based wholly owned independent ... awarded funding from the National Institutes of Health ... dressing that is able to be delivered by ...
Breaking Medicine Technology:GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5
(Date:5/6/2015)... (PRWEB) May 06, 2015 As ... the HIMSS EMR Adoption Model, the hospital looked ... patient engagement and automate processes. The leadership team ... paper-driven to electronic workflows, patient registration still required ... of consents. With HIMSS Stage 7 attestation fast ...
(Date:5/6/2015)... 2015 Qushanna Doby (20) was arrested for ... treatment center in Florida while under the influence of Flakka, ... surveillance tapes released by CBS4’s Peter D’Oench records Doby distraught ... child is around one year old. The drug treatment center ... was not named. The residents polled by CBS Miami express ...
(Date:5/6/2015)... Chesapeake Regional Medical Center is ... to acquire Intuitive Surgical, Inc.’s latest model of ... includes enhanced surgical technique capabilities, which can be ... wide spectrum of specialties. Its advancements allow patients ... recovery times. , “As the only independent, community-based ...
(Date:5/6/2015)... May 06, 2015 Baptist Medical ... the first in north Florida and southeast Georgia ... the latest innovation in total hip replacement surgery ... surgeon-controlled robotic arm that enables the accurate alignment ... Jacksonville has offered MAKOplasty® partial knee resurfacing using ...
(Date:5/6/2015)... 06, 2015 Animals make just as good ... also good for your health. An Ohio veterinarian ... increase he's seeing with health advantages of owning a pet. ... it comes to pet ownership, there are proven health benefits ... Scott Leffler of the Animal Medical Center of ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... members, money to UHW-W,treasury from outside fund, WASHINGTON, ... United Healthcare Workers West (UHW-W) violated federal,law and deceived ... in dues money to an outside fund under their ... SEIU in United States District,Court for the Central District ...
... Revised and expanded YOU: The Owner,s Manual released today, ... got even,better! YOU: The Owner,s Manual, Updated and Expanded ... bookstores today. The original book,published by HarperCollins in 2005, ... the best-selling books across all titles in 2005. The ...
... American Heart Association advocates call on lawmakers to ... With risk factors for,heart disease and stroke steadily ... from across the country today urged,Congress to make ... their,representatives for the American Heart Association,s (AHA) Congressional,Lobby ...
... Ones At ... on May 2, PHOENIX, April 29 Remuda Programs ... inpatient,treatment center for women and girls suffering from eating disorders, ... new book "Distorted -,How a Mother and Daughter Unraveled the ...
... April 29 Elbit Imaging Ltd.,(the "Company") (Nasdaq: ... Fidelity Trust Company Ltd., the trustee for the holders ... Company (the "Trustee" and the "Notes",respectively), that due to ... firms, Zohar, Zohar & Co., the controlling shareholder of,the ...
... normal range associated with dangers , , TUESDAY, April 29 ... normal range may increase the risk of fatal coronary ... Thyrotropin, a hormone produced by the pituitary gland, is ... gland to stimulate its growth and function. , "Emerging ...
Cached Medicine News:Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 2Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 3Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 4Health News:America's Favorite Doctors Try to Outdo Their Own Blockbuster 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 3Health News:Authors Of New Critically Acclaimed Book 'Distorted' Share Their Journey From an Eating Disorder at a Book Signing Event in Wickenburg 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 3Health News:Pituitary Hormone May Boost Women's Heart Risk 2
... versatile power supply in its class. Capable ... 1250 milliamps or 325 watts, it easily ... power supply is capable of providing the ... small focusing gels and the current required ...
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus....
... as submarine electrophoresis and SDS-PAGE, to DNA ... 90 Programmable Power Supplies will support virtually ... Supplies are available in four different output ... operate in constant voltage, current or power ...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
Medicine Products: